Delivery Order SPE2DR25D7005-SPE2DR26F3ERB
- Not listed
- The Defense Logistics Agency awarded a $2,178.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages) on December 8, 2025, with completion scheduled for December 9, 2025. This contract is unset-aside and represents a competitive award to the prime contractor, which maintains its corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) under a firm fixed-price contract valued at $5,891.99, with an ultimate completion date of January 13, 2026. This non-set-aside competitive award was issued on January 12, 2026, with performance taking place at the contractor's location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,284.44 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). The award, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, represents a firm fixed-price delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8,035.99 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30 count) on January 8, 2026, with a completion date of January 9, 2026. This is a firm fixed-price, non-set-aside contract with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count) under a firm fixed-price contract valued at $8,420.18. The award, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this order from its corporate office location. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $8,962.67 under a firm fixed price structure, with an ultimate completion date of August 20, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $15,452.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Ondansetron ODT 8 mg tablets (30-count units), with an ultimate completion date of January 8, 2026. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $15,998.79 to AmerisourceBergen Drug Corp for Ondansetron Orally Disintegrating Tablets 4mg (30-count) on January 9, 2026, with completion targeted for February 6, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a delivery order valued at $31,740.85 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count packages). This competitively awarded, firm fixed-price delivery order was issued on January 9, 2026, with an ultimate completion date of January 12, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside contract, this award reflects open competition in the...
- The Defense Logistics Agency awarded a $18,875.65 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 MG tablets (30-count) with an ultimate completion date of September 10, 2025. This is a firm fixed-price, non-set-aside contract with performance occurring at the vendor's Conshohocken, Pennsylvania location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- SPE2DR25D7005Indefinite Delivery Contract
- SPE2DR25D7005-SPE2DR26F3ERBDelivery Order
The Defense Logistics Agency awarded a $1,151.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on January 13, 2026, with an ultimate completion date of January 14, 2026. This contract was awarded without a set-aside designation on a competitive basis and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen functions as a critical pharmaceutical distributor within the federal medical supply chain, specializing in delivering prescription medications, over-the-counter drugs, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The ondansetron order fulfills medical procurement needs for military and veteran healthcare systems, with ondansetron being an antiemetic commonly used in clinical and surgical settings. This delivery order exemplifies the company's versatility in fulfilling federal medical supply requirements through the DLA's strategic pharmaceutical support vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and other medical supplies essential to military treatment facilities and other government healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/12/26 |